How Digital Platforms Could Reshape Type 1 Diabetes Care for Kids

Managing Type 1 diabetes requires constant attention to blood sugar levels, medication doses, meals, and activity. For families juggling school, sports, and daily life, this can feel overwhelming. Digital platforms that pull together information from continuous glucose monitors, patient observations, and clinical data in one place could help both families and healthcare providers see patterns and act faster.

Despite growing interest in these tools, many digital platforms haven't been widely adopted in clinics or homes. Part of the reason is unclear: we don't fully know whether these platforms actually improve health outcomes, or what gets in the way of families and doctors using them consistently.

Haibu Diabetes is a newly developed digital platform designed to change how pediatric Type 1 diabetes care happens. The platform combines three types of data: readings from wearable devices (like continuous glucose monitors), information families enter themselves, and data from clinical visits. This integrated view gives patients and clinicians a more complete picture of how diabetes management is actually going.

The platform includes tools for clinicians to review data on a dashboard, assign tasks or forms to patients and families, and communicate back and forth asynchronously—meaning conversations don't have to happen in real time, making it more flexible for busy families.

A research team is launching a study at a pediatric diabetes center to evaluate both whether Haibu Diabetes improves health outcomes and how well it gets adopted into routine care. The study will enroll children ages 3 to 17 and their caregivers as they begin using the platform as part of their regular clinic visits.

Researchers will compare the health results of young people using Haibu Diabetes to a matched group of similar children from a diabetes registry who are receiving standard care. They'll measure success using clinical markers like hemoglobin A1C (average blood sugar over three months), time spent in target blood sugar range measured by continuous glucose monitors, and improvements in daily diabetes self-care behaviors.

Beyond just measuring health outcomes, the researchers will study the implementation process itself—looking at what helps or hinders adoption, how workflows need to change, and what strategies work best for getting the platform integrated into clinic routines.

This study represents a practical, real-world test of whether digital platforms can truly make a difference in pediatric Type 1 diabetes care. By examining both clinical outcomes and implementation processes, researchers hope to understand not just whether Haibu Diabetes works, but how to make sure it actually reaches and helps the families who need it most.

Source: JMIR research protocols. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.